North China Pharmaceutical Co Ltd (600812) — Free Cash Flow Generation Index
North China Pharmaceutical Co Ltd (600812) has a Free Cash Flow Generation Index of 0.15x as of September 2025. Free cash flow of CN¥25.86 Million represents 0% of operating cash flow (CN¥170.24 Million). Read total liabilities of North China Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
North China Pharmaceutical Co Ltd Free Cash Flow Generation Index (2000–2025)
Historical FCF Generation Index trend for North China Pharmaceutical Co Ltd across 22 annual periods. Explore capital reinvestment ratio of North China Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for North China Pharmaceutical Co Ltd (2000–2025)
Year-by-year Free Cash Flow Generation Index for North China Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600812 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥634.53 Million | CN¥1.18 Billion | CN¥542.01 Million | ▲ +48.9% |
| 2024 | 0.36x | CN¥445.35 Million | CN¥1.23 Billion | CN¥784.22 Million | ▼ -7.5% |
| 2023 | 0.39x | CN¥401.23 Million | CN¥1.02 Billion | CN¥623.04 Million | ▼ -13.5% |
| 2022 | 0.45x | CN¥454.81 Million | CN¥1.00 Billion | CN¥549.58 Million | ▼ -5.4% |
| 2021 | 0.48x | CN¥502.75 Million | CN¥1.05 Billion | CN¥547.50 Million | ▲ +241.4% |
| 2020 | -0.34x | CN¥-254.68 Million | CN¥752.15 Million | CN¥1.01 Billion | ▼ -385.3% |
| 2019 | 0.12x | CN¥87.00 Million | CN¥732.97 Million | CN¥645.97 Million | ▼ -65.7% |
| 2018 | 0.35x | CN¥267.69 Million | CN¥774.33 Million | CN¥506.64 Million | ▲ +188.3% |
| 2017 | -0.39x | CN¥-112.44 Million | CN¥287.25 Million | CN¥399.69 Million | ▲ +80.5% |
| 2015 | -2.00x | CN¥-245.32 Million | CN¥122.50 Million | CN¥367.81 Million | ▼ -8.1% |
| 2014 | -1.85x | CN¥-167.73 Million | CN¥90.56 Million | CN¥258.30 Million | ▲ +53.6% |
| 2011 | -3.99x | CN¥-909.21 Million | CN¥227.60 Million | CN¥1.14 Billion | ▼ -726.2% |
| 2009 | 0.64x | CN¥645.03 Million | CN¥1.01 Billion | CN¥366.10 Million | ▼ -26.9% |
| 2008 | 0.87x | CN¥947.52 Million | CN¥1.09 Billion | CN¥138.00 Million | ▲ +2.4% |
| 2007 | 0.85x | CN¥566.10 Million | CN¥664.37 Million | CN¥98.27 Million | ▼ -6.7% |
| 2006 | 0.91x | CN¥545.39 Million | CN¥597.12 Million | CN¥51.72 Million | ▲ +418.3% |
| 2005 | 0.18x | CN¥39.50 Million | CN¥224.17 Million | CN¥184.67 Million | ▲ +243.5% |
| 2004 | -0.12x | CN¥-38.11 Million | CN¥310.39 Million | CN¥348.50 Million | ▼ -151.8% |
| 2003 | 0.24x | CN¥137.54 Million | CN¥580.32 Million | CN¥442.77 Million | ▼ -65.9% |
| 2002 | 0.70x | CN¥513.82 Million | CN¥738.50 Million | CN¥224.68 Million | ▲ +45.6% |
| 2001 | 0.48x | CN¥175.49 Million | CN¥367.28 Million | CN¥191.79 Million | ▲ +77.3% |
| 2000 | 0.27x | CN¥35.97 Million | CN¥133.49 Million | CN¥97.52 Million | — |